2nd Quarter - Report

EMERGENT BIOSOLUTIONS INC. for EMERGENT BIOSOLUTIONS INC

Period 2nd Quarter 2009 Filed Jul 20, 2009 Signed by Allen M. Shofe, Senior Vice-President, Public Affairs

Official filing
Firm
EMERGENT BIOSOLUTIONS INC.
Client
EMERGENT BIOSOLUTIONS INC
Income
—
Expenses
$610,000
Expense method
C: businesses, Internal Revenue Code section 162(e)

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Homeland Security HOM

P.L. 115-5-American Recovery & Reinvestment Act of 2009 - implementation of provisions relating to biodefense funding; Departments of Labor, Health & Human Services and Education Appropriations for 2010 - all provisions relating to development, acquisition and stockpiling of biodefense vaccines.

LobbyistCovered position, as disclosed
ASHLEY BRATICH —
CHRIS FRECH —
ALLEN SHOFE —

Contacted: Defense, Dept of (DOD); HOUSE OF REPRESENTATIVES; Homeland Security, Dept of (DHS); SENATE; Health & Human Services, Dept of (HHS)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.